A detailed history of Nissay Asset Management Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Nissay Asset Management Corp holds 20,620 shares of EXAS stock, worth $934,085. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,620
Previous 20,277 1.69%
Holding current value
$934,085
Previous $1.5 Million 5.07%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $19,300 - $25,303
343 Added 1.69%
20,620 $1.42 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $44,235 - $56,714
749 Added 3.84%
20,277 $1.5 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $57,499 - $86,362
872 Added 4.67%
19,528 $1.33 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $23,567 - $35,738
-376 Reduced 1.98%
18,656 $1.75 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $39,356 - $59,022
-834 Reduced 4.2%
19,032 $1.29 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $880 - $1,541
-29 Reduced 0.15%
19,866 $983,000
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $30,339 - $46,852
949 Added 5.01%
19,895 $646,000
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $17,199 - $36,819
483 Added 2.62%
18,946 $746,000
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $27,110 - $38,876
471 Added 2.62%
18,463 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $56,477 - $78,429
779 Added 4.53%
17,992 $1.4 Million
Q3 2021

Nov 10, 2021

BUY
$90.24 - $124.05 $82,659 - $113,629
916 Added 5.62%
17,213 $1.64 Million
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $135,245 - $201,105
1,444 Added 9.72%
16,297 $2.03 Million
Q1 2021

May 11, 2021

SELL
$116.57 - $155.01 $42,198 - $56,113
-362 Reduced 2.38%
14,853 $1.96 Million
Q4 2020

Feb 08, 2021

BUY
$99.61 - $142.12 $66,141 - $94,367
664 Added 4.56%
15,215 $2.02 Million
Q3 2020

Oct 20, 2020

BUY
$72.92 - $102.01 $39,960 - $55,901
548 Added 3.91%
14,551 $1.48 Million
Q2 2020

Jul 27, 2020

BUY
$55.75 - $92.75 $85,074 - $141,536
1,526 Added 12.23%
14,003 $1.22 Million
Q1 2020

May 05, 2020

BUY
$37.9 - $104.44 $19,329 - $53,264
510 Added 4.26%
12,477 $724,000
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $127,440 - $163,673
1,641 Added 15.89%
11,967 $1.11 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $69,494 - $94,194
769 Added 8.05%
10,326 $933,000
Q2 2019

Aug 07, 2019

BUY
$89.51 - $118.04 $855,447 - $1.13 Million
9,557 New
9,557 $1.13 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.02B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.